# AMBRISENTAN

NDC: 42794-052
Generic name: AMBRISENTAN
Labeler / Manufacturer: Sigmapharm Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20190410

FDA application: ANDA208354

## Active ingredients

- AMBRISENTAN: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42794-052"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42794-052
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e20ab2fe-bc9f-48a3-b15a-e4bc9532c2ac